Cargando…

Insulin Resistance as a Therapeutic Target in the Treatment of Alzheimer's Disease: A State-of-the-Art Review

Research in animals and humans has shown that type 2 diabetes and its prodromal state, insulin resistance, promote major pathological hallmarks of Alzheimer's disease (AD), such as the formation of amyloid plaques and neurofibrillary tangles (NFT). Worrisomely, dysregulated amyloid beta (Aβ) me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benedict, Christian, Grillo, Claudia A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932355/ https://www.ncbi.nlm.nih.gov/pubmed/29743868 http://dx.doi.org/10.3389/fnins.2018.00215

Ejemplares similares

Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer’s Disease
por: Vinuesa, Angeles, et al.
Publicado: (2021)

Insulin Resistance in Alzheimer's Disease
por: Ferreira, Laís S. S., et al.
Publicado: (2018)

Intranasal insulin in Alzheimer’s disease: Food for thought
por: Chapman, Colin D., et al.
Publicado: (2018)

Insulin Resistance and Alzheimer’s Disease: Bioenergetic Linkages
por: Neth, Bryan J., et al.
Publicado: (2017)

Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond
por: Wang, Xiaoli, et al.
Publicado: (2020)

Corrigendum: Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond
por: Wang, Xiaoli, et al.
Publicado: (2020)

TLR4 Targeting as a Promising Therapeutic Strategy for Alzheimer Disease Treatment
por: Zhou, Yongji, et al.
Publicado: (2020)

Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease
por: de la Monte, Suzanne M
Publicado: (2012)

Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS
por: Gourdon, Genevieve, et al.
Publicado: (2017)

Insulin resistance in the brain: A new therapeutic target for Alzheimer's disease
por: Umegaki, Hiroyuki
Publicado: (2013)

Meta-Review of CSF Core Biomarkers in Alzheimer’s Disease: The State-of-the-Art after the New Revised Diagnostic Criteria
por: Ferreira, Daniel, et al.
Publicado: (2014)

EAAT2 as a therapeutic research target in Alzheimer's disease: A systematic review
por: Wood, Oliver W. G., et al.
Publicado: (2022)

Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms
por: Wei, Zenghui, et al.
Publicado: (2021)

Pyroptosis as a candidate therapeutic target for Alzheimer’s disease
por: Huang, Yuehua, et al.
Publicado: (2022)

Implications of Resveratrol in Obesity and Insulin Resistance: A State-of-the-Art Review
por: Barber, Thomas M., et al.
Publicado: (2022)

Neuroinflammation and the Gut Microbiota: Possible Alternative Therapeutic Targets to Counteract Alzheimer’s Disease?
por: Cerovic, Milica, et al.
Publicado: (2019)

The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia
por: Folch, Jaume, et al.
Publicado: (2019)

Inhibition of phosphodiesterase: A novel therapeutic target for the treatment of mild cognitive impairment and Alzheimer’s disease
por: Sheng, Jianwen, et al.
Publicado: (2022)

Coupling Resistive Switching Devices with Neurons: State of the Art and Perspectives
por: Chiolerio, Alessandro, et al.
Publicado: (2017)

State of the Art of microRNAs Signatures as Biomarkers and Therapeutic Targets in Parkinson’s and Alzheimer’s Diseases: A Systematic Review and Meta-Analysis
por: Zotarelli-Filho, Idiberto José, et al.
Publicado: (2023)

Insulin Signaling Impairment in the Brain as a Risk Factor in Alzheimer’s Disease
por: Hölscher, Christian
Publicado: (2019)

Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer’s Disease
por: Mullins, Roger J., et al.
Publicado: (2017)

The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease
por: Cellai, Lucrezia, et al.
Publicado: (2018)

Targeting TNFR2 as a Novel Therapeutic Strategy for Alzheimer’s Disease
por: Ortí-Casañ, Natalia, et al.
Publicado: (2019)

Targeting Secondary Hematoma Expansion in Spontaneous Intracerebral Hemorrhage – State of the Art
por: Guan, Jian, et al.
Publicado: (2016)

Targeting multiple pathogenic mechanisms with polyphenols for the treatment of Alzheimer's disease-experimental approach and therapeutic implications
por: Wang, Jun, et al.
Publicado: (2014)

Neuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's Disease
por: Snow, Wanda M., et al.
Publicado: (2016)

The state of the art in organizational cognitive neuroscience: the therapeutic gap and possible implications for clinical practice
por: Senior, Carl, et al.
Publicado: (2013)

Microglia in Alzheimer’s Disease: A Target for Therapeutic Intervention
por: Zhang, Guimei, et al.
Publicado: (2021)

Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer’s disease
por: Nalivaeva, Natalia N., et al.
Publicado: (2014)

Targeting Beta-Amyloid at the CSF: A New Therapeutic Strategy in Alzheimer’s Disease
por: Menendez-Gonzalez, Manuel, et al.
Publicado: (2018)

Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer’s Disease
por: Zhu, Feiqi, et al.
Publicado: (2020)

Sirtuins as Potential Therapeutic Targets for Mitigating Neuroinflammation Associated With Alzheimer’s Disease
por: Fernando, Kurukulasooriya Kavindya Madushani, et al.
Publicado: (2021)

Suppressor of Cytokine Signaling 3: Emerging Role Linking Central Insulin Resistance and Alzheimer’s Disease
por: Cao, Lan, et al.
Publicado: (2018)

Perspectives on ROCK2 as a Therapeutic Target for Alzheimer’s Disease
por: Weber, Audrey J., et al.
Publicado: (2021)

Non-invasive Brain Stimulation in Alzheimer's Disease and Mild Cognitive Impairment—A State-of-the-Art Review on Methodological Characteristics and Stimulation Parameters
por: Holczer, Adrienn, et al.
Publicado: (2020)

Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer’s disease
por: Coles, Madilyn, et al.
Publicado: (2022)

Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence
por: Freiherr, Jessica, et al.
Publicado: (2013)

The Nuclear Receptor PPARγ as a Therapeutic Target for Cerebrovascular and Brain Dysfunction in Alzheimer's Disease
por: Nicolakakis, Nektaria, et al.
Publicado: (2010)

Alzheimer’s Disease and microRNA-132: A Widespread Pathological Factor and Potential Therapeutic Target
por: Zhang, Meng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mg5rmdu3ofbm9au3739thunl2o